{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T20:15:00Z","timestamp":1793218500847,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.jad.2021.10.074","type":"journal-article","created":{"date-parts":[[2021,10,31]],"date-time":"2021-10-31T02:29:00Z","timestamp":1635647340000},"page":"623-633","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Alzheimer's disease related biomarkers in bipolar disorder \u2013 A longitudinal one-year case-control study"],"prefix":"10.1016","volume":"297","author":[{"given":"Ulla","family":"Knorr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja Hviid","family":"Simonsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla Steen","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten","family":"Akh\u00f8j","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Forman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steen Gregers","family":"Hasselbalch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars Vedel","family":"Kessing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2021.10.074_bib0001","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jad.2014.06.050","article-title":"A systematic review of amyloid-beta peptides as putative mediators of the association between affective disorders and Alzheimers disease","volume":"168","author":"Abbasowa","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2021.10.074_bib0002","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jpsychires.2019.03.019","article-title":"Neurofilament light chain as a blood biomarker to differentiate psychiatric disorders from behavioural variant frontotemporal dementia","volume":"113","author":"Al Shweiki","year":"2019","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2021.10.074_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2020.109922","article-title":"Glial and neuronal markers in bipolar disorder: a meta-analysis testing S100B and NSE peripheral blood levels","volume":"101","author":"Bartoli","year":"2020","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2021.10.074_bib0004","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1017\/S0033291717001490","article-title":"Meta-analysis of longitudinal studies of cognition in bipolar disorder: comparison with healthy controls and schizophrenia","volume":"47","author":"Bora","year":"2017","journal-title":"Psychol. Med."},{"issue":"1","key":"10.1016\/j.jad.2021.10.074_bib0005","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/bdi.12748","article-title":"The international consortium investigating neurocognition in bipolar disorder (ICONIC-BD)","volume":"21","author":"Burdick","year":"2019","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2021.10.074_bib0006","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1056\/NEJMra1906193","article-title":"Bipolar disorder","volume":"383","author":"Carvalho","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jad.2021.10.074_bib0007","first-page":"1","article-title":"Understanding cognitive impairment in mood disorders: mediation analyses in the UK Biobank cohort","author":"Cullen","year":"2019","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2021.10.074_bib0008","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1192\/bjp.bp.111.101931","article-title":"Affective disorders and risk of developing dementia: systematic review","volume":"202","author":"da Silva","year":"2013","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2021.10.074_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101283","article-title":"Oxidative inactivation of amyloid beta-degrading proteases by cholesterol-enhanced mitochondrial stress","volume":"26","author":"de Dios","year":"2019","journal-title":"Redox. Biol."},{"key":"10.1016\/j.jad.2021.10.074_bib0010","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.jalz.2015.05.012","article-title":"C-terminal neurogranin is increased in cerebrospinal fluid but unchanged in plasma in Alzheimer's disease","volume":"11","author":"De Vos","year":"2015","journal-title":"Alzheimer's Dement. J. Alzheimer's Assoc."},{"issue":"8","key":"10.1016\/j.jad.2021.10.074_bib0011","doi-asserted-by":"crossref","first-page":"870","DOI":"10.2174\/1567205014666170317113606","article-title":"Impact of cytokines and chemokines on Alzheimer's disease neuropathological hallmarks","volume":"14","author":"Domingues","year":"2017","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.jad.2021.10.074_bib0012","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/bdi.12360","article-title":"Cognitive impairment in late-life bipolar disorder is not associated with Alzheimer's disease pathological signature in the cerebrospinal fluid","volume":"18","author":"Forlenza","year":"2016","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2021.10.074_bib0013","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.jclinepi.2014.03.012","article-title":"False discovery rate control is a recommended alternative to Bonferroni-type adjustments in health studies","volume":"67","author":"Glickman","year":"2014","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.jad.2021.10.074_bib0014","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8050651","article-title":"Vascular dysfunction in Alzheimer's disease: a prelude to the pathological process or a consequence of it?","volume":"8","author":"Govindpani","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jad.2021.10.074_bib0015","doi-asserted-by":"crossref","first-page":"456","DOI":"10.3389\/fimmu.2020.00456","article-title":"A path toward precision medicine for neuroinflammatory mechanisms in Alzheimer's disease","volume":"11","author":"Hampel","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jad.2021.10.074_bib0016","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.jalz.2018.05.008","article-title":"The impact of preanalytical variables on measuring cerebrospinal fluid biomarkers for Alzheimer's disease diagnosis: a review","volume":"14","author":"Hansson","year":"2018","journal-title":"Alzheimer's Dement. J. Alzheimer's Assoc."},{"key":"10.1016\/j.jad.2021.10.074_bib0017","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimer's Dement. J. Alzheimer's Assoc."},{"key":"10.1016\/j.jad.2021.10.074_bib0018","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1038\/npp.2014.81","article-title":"Elevated concentrations of neurofilament light chain in the cerebrospinal fluid of bipolar disorder patients","volume":"39","author":"Jakobsson","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2021.10.074_bib0019","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/npp.2012.231","article-title":"Altered concentrations of amyloid precursor protein metabolites in the cerebrospinal fluid of patients with bipolar disorder","volume":"38","author":"Jakobsson","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2021.10.074_bib0020","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.eurpsy.2018.11.008","article-title":"Neurocognition and functional outcome in patients with psychotic, non-psychotic bipolar I disorder, and schizophrenia. A five-year follow-up","volume":"56","author":"Jimenez-Lopez","year":"2019","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.jad.2021.10.074_bib0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroimage.2012.03.077","article-title":"Effects of beta-amyloid accumulation on neural function during encoding across the adult lifespan","volume":"62","author":"Kennedy","year":"2012","journal-title":"Neuroimage"},{"key":"10.1016\/j.jad.2021.10.074_bib0022","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/bdi.12367","article-title":"Apolipoprotein E genotype is not associated with cognitive impairment in older adults with bipolar disorder","volume":"18","author":"Kerr","year":"2016","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2021.10.074_bib0023","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/acps.12667","article-title":"Evidence for clinical progression of unipolar and bipolar disorders","volume":"135","author":"Kessing","year":"2017","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2021.10.074_bib0024","first-page":"1","article-title":"Aberrant cognition in newly diagnosed patients with bipolar disorder and their unaffected relatives","author":"Kjaerstad","year":"2019","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2021.10.074_bib0025","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jad.2020.09.055","article-title":"The impact of the trajectory of bipolar disorder on global cognitive function: a one-year clinical prospective case-control study","volume":"278","author":"Knorr","year":"2020","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2021.10.074_bib0026","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/s41398-019-0664-6","article-title":"Cerebrospinal fluid oxidative stress metabolites in patients with bipolar disorder and healthy controls: a longitudinal case-control study","volume":"9","author":"Knorr","year":"2019","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jad.2021.10.074_bib0027","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.euroneuro.2018.04.002","article-title":"Biomarkers in cerebrospinal fluid of patients with bipolar disorder versus healthy individuals: a systematic review","volume":"28","author":"Knorr","year":"2018","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2021.10.074_bib0028","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1515\/cclm.2002.197","article-title":"TaqMan systems for genotyping of disease-related polymorphisms present in the gene encoding apolipoprotein E","volume":"40","author":"Koch","year":"2002","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.jad.2021.10.074_bib0029","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1080\/15622975.2017.1375556","article-title":"Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: an update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry","volume":"19","author":"Lewczuk","year":"2018","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2021.10.074_bib0030","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2020-323497","article-title":"Anti-A\u03b2 agents for mild to moderate Alzheimer's disease: systematic review and meta-analysis","author":"Lu","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jad.2021.10.074_bib0031","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jalz.2013.01.010","article-title":"CSF biomarker variability in the Alzheimer's Association quality control program","volume":"9","author":"Mattsson","year":"2013","journal-title":"Alzheimer's Dement. J. Alzheimer's Assoc."},{"key":"10.1016\/j.jad.2021.10.074_bib0032","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/acn3.81","article-title":"Diagnostic accuracy of CSF Ab42 and florbetapir PET for Alzheimer's disease","volume":"1","author":"Mattsson","year":"2014","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.jad.2021.10.074_bib0033","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0140-6736(12)61689-4","article-title":"Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Murray","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2021.10.074_bib0034","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13195-020-00586-6","article-title":"Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course-a joint PhD student course at University College London and University of Gothenburg","volume":"12","author":"Obrocki","year":"2020","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.jad.2021.10.074_bib0035","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.dadm.2019.08.008","article-title":"Cerebrospinal fluid and plasma neurofilament light relate to abnormal cognition","volume":"11","author":"Osborn","year":"2019","journal-title":"Alzheimers Dement. (Amst)"},{"key":"10.1016\/j.jad.2021.10.074_bib0036","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/acps.12581","article-title":"Areas of controversy in neuroprogression in bipolar disorder","volume":"134","author":"Passos","year":"2016","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2021.10.074_bib0037","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jalz.2011.10.003","article-title":"Cerebrospinal fluid markers for Alzheimer's disease in a cognitively healthy cohort of young and old adults","volume":"8","author":"Paternico","year":"2012","journal-title":"Alzheimer's Dement. J. Alzheimer's Assoc."},{"key":"10.1016\/j.jad.2021.10.074_bib0038","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jad.2011.12.042","article-title":"Plasma beta-amyloid peptides levels: a pilot study in bipolar depressed patients","volume":"138","author":"Piccinni","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2021.10.074_bib0039","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3233\/JAD-2010-100561","article-title":"Cerebrospinal fluid markers for Alzheimer's disease over the lifespan: effects of age and the APOEepsilon4 genotype","volume":"22","author":"Popp","year":"2010","journal-title":"J. Alzheimer's Dis. JAD"},{"key":"10.1016\/j.jad.2021.10.074_bib0040","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00401-018-1851-x","article-title":"Cerebrospinal fluid neurogranin concentration in neurodegeneration: relation to clinical phenotypes and neuropathology","volume":"136","author":"Portelius","year":"2018","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jad.2021.10.074_bib0041","article-title":"Fluid transport in the brain","author":"Rasmussen","year":"2021","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.jad.2021.10.074_bib0043","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1002\/hbm.22788","article-title":"The effect of beta-amyloid on face processing in young and old adults: a multivariate analysis of the BOLD signal","volume":"36","author":"Rieck","year":"2015","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.jad.2021.10.074_bib0044","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jpsychires.2017.03.018","article-title":"A systematic review of evidence for the role of inflammatory biomarkers in bipolar patients","volume":"92","author":"Sayana","year":"2017","journal-title":"J. Psychiatr. Res."},{"issue":"1","key":"10.1016\/j.jad.2021.10.074_bib0045","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/bdi.12841","article-title":"Longitudinal analysis of cognitive performances in recent-onset and late-life Bipolar Disorder: a systematic review and meta-analysis","volume":"22","author":"Szmulewicz","year":"2020","journal-title":"Bipolar Disord."},{"issue":"1","key":"10.1016\/j.jad.2021.10.074_bib0046","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s12017-019-08561-7","article-title":"CSF sAPPalpha and sAPPbeta levels in Alzheimer's Disease and Multiple Other Neurodegenerative Diseases: a Network Meta-Analysis","volume":"22","author":"Tang","year":"2020","journal-title":"Neuromolecular Med"},{"key":"10.1016\/j.jad.2021.10.074_bib0047","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21030934","article-title":"Ketone bodies promote amyloid-beta1-40 clearance in a human in vitro blood-brain barrier model","volume":"21","author":"Versele","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jad.2021.10.074_bib0048","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1038\/s41467-020-15701-2","article-title":"Spread of pathological tau proteins through communicating neurons in human Alzheimer's disease","volume":"11","author":"Vogel","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jad.2021.10.074_bib0049","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.psychres.2014.03.045","article-title":"Blood-cerebrospinal fluid barrier dysfunction in patients with bipolar disorder in relation to antipsychotic treatment","volume":"217","author":"Zetterberg","year":"2014","journal-title":"Psychiatry Res."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032721011587?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032721011587?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T02:33:39Z","timestamp":1759026819000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032721011587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":48,"alternative-id":["S0165032721011587"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2021.10.074","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alzheimer's disease related biomarkers in bipolar disorder \u2013 A longitudinal one-year case-control study","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2021.10.074","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}